tykhr
sign in
free sign up
Regencell Bioscience Holdings Ltd
Drug Manufacturers - Specialty & Generic
Healthcare
RGC
494 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
15.44
52 week high
877.00
high
15.44
52 week low
0.00
low
14.67
growth
134.50 %
previous Close
15.44
P/E ratio
market cap
7.22 B
div yield
0
usd
Sep 2022
qoq
revenue
-2.34 B
0.00 %
net incoming
-1.61 K
16.29 %
eps
0.00 %
-3.45 %
eps surprise
0.00 %
net profit margin
0.00 %
0.00 %
operating incoming
-1.71 K
13.39 %
net change in cash
6.19 B
0.00 %
cash on hand
6.42 M
0.00 %
cost of revenue
604 K
0.00 %
top